Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GERN · against 557 other Healthcare companies listed in US-listed
Ranked #298 of 558 · scores higher than 45% of peers
Bars: peers in each 10-point band of the profitability score82 peers with a profitability score of 20–29, including GERN · Click a bar to see the companies
Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | GERN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -14.8% | -7.0% | 46% | 33% | |
| Operating marginHigher is better · 479 reported | -28.0% | -2.4% | 36% | 33% | |
| Return on assetsHigher is better · 582 reported | -13.0% | -7.8% | 44% | 33% | |
| Return on equityHigher is better · 531 reported | -28.3% | -19.7% | 44% | Context only | |
| Gross marginHigher is better · 601 reported | 58.5% | 43.9% | 62% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 289 | 2.0B USD | 25 | 53 | |
| 289 | 14.0B USD | 25 | 31 | |
| 298 | 21.8B USD | 24 | 32 | |
| 298 | 775M USD | 24 | 31 | |
| 298 | 598M USD | 24 | 49 | |
| 298 | 1.5B USD | 24 | 44 | |
| 298 | 423M USD | 24 | 29 | |
| 298 | 8.8B USD | 24 | 50 | |
| 298 | 513M USD | 24 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score